Showing posts with label Healthcare. Show all posts
Showing posts with label Healthcare. Show all posts

Monday, February 27, 2017

High-Momentum Healthcare Stocks: MannKind Corporation (MNKD), PharmAthene, Inc. (PIP)

MannKind Corporation (NASDAQ:MNKD) shares ended at $ 0.51 with 1.58 mln shares exchanging hands. That puts the market capitalization at $ 239.85 mln. It opened the session with a $ 0.501 price tag, later ranging from $ 0.4924 to $ 0.519, the range at which the stock has traded at throughout the day. The stock stands nearly -77.05% off versus the 52-week high and 25.39% away from the 52-week low. The number of shares currently owned by investors are 466.54 mln.

Sell-side analyst recommendations point to a short term price target of $ on the shares of MannKind Corporation (MNKD). The consensus rating is 4, suggesting the market has given up on the stock. It has been assigned a low target price of $ and a high target price of $ .

The current price is staying below the SMA lines which signify weakens and is generally unhealthy/negative and may provide the momentum for driving the share price lower. Current price places the company’s stock -32.73% away from its 200-day simple moving average, -17.97%, away from the 50-day average and also -9.56% away from 20-day average.

For this year, MannKind Corporation (NASDAQ:MNKD) is performing -19.26%. Over the past five trading sessions it is -4.18%; -24.44% for the month; -11.35% for the last quarter; -40.91% for the past six-months; and -52.4% for the last 12 months. The last close places the company’s stock about $ 1.73 off its 52 week high of $ 2.24 and $ 0.1 above the 52 week low of $ 0.41.

PharmAthene, Inc. (NYSEMKT:PIP) closed up +0.02 points or 1.66% at $ 0.93 with 1.53 mln shares exchanging hands. Current price level places the company’s stock about -73.57% from the 52-week high and 96.83% away from the 52-week low. The consensus rating is 2, indicating analysts in general look favorably on the company’s future prospects.

PharmAthene, Inc. (PIP) opened the session with a $ 0.88 price tag, later ranging from $ 0.88 to $ 0.97, the range at which the stock has traded at throughout the day. The stock stands nearly $ 2.62 off versus the 52-week high of $ 3.5 and $ 0.41 above the 52-week low of $ 0.47. The number of shares currently owned by investors are 65.62 mln. The current price change puts the market capitalization at $ 60.71 mln.

Over the past five trading sessions shares of PharmAthene, Inc. (NYSEMKT:PIP) are -11.9%; -71.54% for the month; -70.16% for the last quarter; -63.86% for the past six-months; and -42.9% for the last 12 months.The current price is staying below the SMA lines which signify weakens and is generally unhealthy/negative and may provide the momentum for driving the share price lower. Current price places the company’s stock -65.02% away from its 200-day simple moving average, -65.7%, away from the 50-day average and also -48.99% away from 20-day average. The stock is performing -71.54% year to date.

The Wellesleys News

High-Momentum Healthcare Stocks: MannKind Corporation (MNKD), PharmAthene, Inc. (PIP)

Wednesday, February 15, 2017

High Volume Healthcare Stocks Roundup: Zoetis Inc. (ZTS), Geron Corporation (GERN)

Zoetis Inc. (NYSE:ZTS) shares ended at $ 55.02 with 5.22 mln shares exchanging hands. That puts the market capitalization at $ 27.28 bln. It opened the session with a $ 55.14 price tag, later ranging from $ 54.79 to $ 55.26, the range at which the stock has traded at throughout the day. The stock stands nearly -2.62% off versus the 52-week high and 40.96% away from the 52-week low. The number of shares currently owned by investors are 495.87 mln.

Sell-side analyst recommendations point to a short term price target of $ 58.71 on the shares of Zoetis Inc. (ZTS). The consensus rating is 1.9, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $ 49 and a high target price of $ 65.

The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock 9.36% away from its 200-day simple moving average, 3.18%, away from the 50-day average and also 0.53% away from 20-day average.

For this year, Zoetis Inc. (NYSE:ZTS) is performing 2.99%. Over the past five trading sessions it is -1.71%; 2.58% for the month; 8.93% for the last quarter; 5.46% for the past six-months; and 37.2% for the last 12 months. The last close places the company’s stock about $ 1.48 off its 52 week high of $ 56.5 and $ 15.67 above the 52 week low of $ 39.35.

Geron Corporation (NASDAQ:GERN) closed up +0.06 points or 2.54% at $ 2.42 with 4.25 mln shares exchanging hands. Current price level places the company’s stock about -27.76% from the 52-week high and 33.7% away from the 52-week low. Sell-side analyst recommendations point to a short term price target of $ 5 on the company shares. The consensus rating is 2, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $ 5 and a high target price of $ 5.

Geron Corporation (GERN) opened the session with a $ 2.35 price tag, later ranging from $ 2.2 to $ 2.45, the range at which the stock has traded at throughout the day. The stock stands nearly $ 1 off versus the 52-week high of $ 3.35 and $ 0.54 above the 52-week low of $ 1.81. The number of shares currently owned by investors are 159.14 mln. The current price change puts the market capitalization at $ 385.12 mln.

In an overview of the current analyst recommendations, Buy count is 1 and Overweight is 0 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. Also, the Hold rating count is 0 as of 02/14/17. The analyst recommendations from a month ago are 2 Buy, 0 Overweight, 0 Sell, 2 Hold and 0 Underweight. Investors might also notice that three month ago the Buy recommendations (3) outnumbered Sell recommendations (0). The count of Hold ratings in that period was 3.

Over the past five trading sessions shares of Geron Corporation (NASDAQ:GERN) are 15.79%; 14.69% for the month; 10% for the last quarter; -15.68% for the past six-months; and -10.7% for the last 12 months. The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock 0.44% away from its 200-day simple moving average, 16.22%, away from the 50-day average and also 18.28% away from 20-day average. The stock is performing 16.91% year to date.

High Volume Healthcare Stocks Roundup: Zoetis Inc. (ZTS), Geron Corporation (GERN)

Wednesday, January 25, 2017

Healthcare Shares Need To Consider: GenVec, Inc. (NASDAQ:GNVC), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM)

GenVec, Inc. (NASDAQ:GNVC) shares ended at $ 6.57 with 1.67 mln shares exchanging hands. That puts the market capitalization at $ 14.72 mln. It opened the session with a $ 6.12 price tag, later ranging from $ 6.11 to $ 7.14, the range at which the stock has traded at throughout the day. The stock stands nearly -53.07% off versus the 52-week high and 143.33% away from the 52-week low. The number of shares currently owned by investors are 2.24 mln.

Sell-side analyst recommendations point to a short term price target of $ 15 on the shares of GenVec, Inc. (GNVC). The consensus rating is 2, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $ 15 and a high target price of $ 15.

The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock 22.9% away from its 200-day simple moving average, 70.53%, away from the 50-day average and also 42.64% away from 20-day average.

For this year, GenVec, Inc. (NASDAQ:GNVC) is performing 104.67%. Over the past five trading sessions it is 7.18%; 107.26% for the month; 72.89% for the last quarter; 11.36% for the past six-months; and 31.4% for the last 12 months. The last close places the company’s stock about $ 3.87 off its 52 week high of $ 10.44 and $ 6.3 above the 52 week low of $ 0.27.

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) closed up +0.02 points or 4.93% at $ 0.31 with 1.67 mln shares exchanging hands. Current price level places the company’s stock about -72.66% from the 52-week high and 9.36% away from the 52-week low. The consensus rating is 1.5, indicating analysts in general look favorably on the company’s future prospects.

Peregrine Pharmaceuticals, Inc. (PPHM) opened the session with a $ 0.292 price tag, later ranging from $ 0.2857 to $ 0.31, the range at which the stock has traded at throughout the day. The stock stands nearly $ 0.83 off versus the 52-week high of $ 1.12 and $ 0.01 above the 52-week low of $ 0.28. The number of shares currently owned by investors are 259.03 mln. The current price change puts the market capitalization at $ 79.31 mln.

Over the past five trading sessions shares of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) are 5.59%; -1.23% for the month; -9.94% for the last quarter; -17.24% for the past six-months; and -70.27% for the last 12 months. The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock -16.4% away from its 200-day simple moving average, -1.92%, away from the 50-day average and also 0.4% away from 20-day average. The stock is performing -1.23% year to date.

The Wellesleys News

Healthcare Shares Need To Consider: GenVec, Inc. (NASDAQ:GNVC), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM)

Thursday, January 19, 2017

Heavy Volume Healthcare Stocks: Egalet Corporation (NASDAQ:EGLT), Provectus Biopharmaceuticals, Inc. (OTC:PVCT)

Egalet Corporation (NASDAQ:EGLT) shares ended at $ 5.13 with 1.59 mln shares exchanging hands. That puts the market capitalization at $ 133.12 mln. It opened the session with a $ 5.24 price tag, later ranging from $ 5.06 to $ 5.65, the range at which the stock has traded at throughout the day. The stock stands nearly -48.7% off versus the 52-week high and 18.2% away from the 52-week low. The number of shares currently owned by investors are 25.95 mln.

Sell-side analyst recommendations point to a short term price target of $ 20.25 on the shares of Egalet Corporation (EGLT). The consensus rating is 2, indicating analysts in general look favorably on the company’s future prospects. It has been assigned a low target price of $ 15 and a high target price of $ 24.

The current price is staying below the SMA lines which signify weakens and is generally unhealthy/negative and may provide the momentum for driving the share price lower. Current price places the company’s stock -24.72% away from its 200-day simple moving average, -30.91%, away from the 50-day average and also -32.82% away from 20-day average.

For this year, Egalet Corporation (NASDAQ:EGLT) is performing -32.94%. Over the past five trading sessions it is -21.32%; -26.82% for the month; -34.4% for the last quarter; -13.49% for the past six-months; and -35.31% for the last 12 months. The last close places the company’s stock about $ 4.87 off its 52 week high of $ 10 and $ 0.79 above the 52 week low of $ 4.34.

Provectus Biopharmaceuticals, Inc. (OTC:PVCT) closed down 0 points or 2.99% at $ 0.02 with 1.58 mln shares exchanging hands. Current price level places the company’s stock about -96.8% from the 52-week high and 56.36% away from the 52-week low. The consensus rating is 2, indicating analysts in general look favorably on the company’s future prospects. I

Provectus Biopharmaceuticals, Inc. (PVCT) opened the session with a $ 0.0175 price tag, later ranging from $ 0.017 to $ 0.0198, the range at which the stock has traded at throughout the day. The stock stands nearly $ 0.52 off versus the 52-week high of $ 0.54 and $ 0.02 above the 52-week low of $ 0. The number of shares currently owned by investors are 243.9 mln. The current price change puts the market capitalization at $ 4.19 mln.

Over the past five trading sessions shares of Provectus Biopharmaceuticals, Inc. (OTC:PVCT) are -1.15%; 23.74% for the month; -49.41% for the last quarter; -94.79% for the past six-months; and -95.27% for the last 12 months. The current price is staying above the SMA lines which signify strength and is generally healthy/positive and may provide the momentum for driving the share price higher. Current price places the company’s stock -91.53% away from its 200-day simple moving average, -33.03%, away from the 50-day average and also 1.22% away from 20-day average. The stock is performing -12.24% year to date.

The Wellesleys News

Heavy Volume Healthcare Stocks: Egalet Corporation (NASDAQ:EGLT), Provectus Biopharmaceuticals, Inc. (OTC:PVCT)

Friday, January 13, 2017

Enter to Win $50 Amazon Gift Card: United Healthcare Is the Easy Choice for Small Businesses #ad

See details on how to enter for a chance to win a $ 50 Amazon Gift Card at the end of this post.

Unfortunately, my birthday is right at the end of January. Twenty-five days after the Affordable Care Act was implemented, I turned 26. I therefore became too old under the new law to be covered through my parents.

United Healthcare Is the Easy Choice for Small Businesses I was 25 when Obamacare went into effect. I had been off my parents’ health insurance plan for some time and had already had some adventures in trying to find affordable coverage on my own.

Finding affordable health insurance has been a consistent frustration of my adult life. I have only had one job that provided coverage for me, and my employer only offered it for a short time. Consequently, a job that pays a decent wage while also offering health insurance would be extremely attractive to me, as it would be to many job applicants.

In fact, a recent LinkedIn survey found that one of the primary reasons why people leave their jobs is dissatisfaction with pay and benefits. Given this situation, it’s in the interest of any organization to do what it can to offer its employees affordable health coverage. And one insurance company making it easier for small businesses to do just that is United Healthcare.

A New and Simpler Way to Shop for Health Insurance

United Healthcare has created a new site particularly suited to the needs of small businesses. Instead of going through the hassle of talking to an associate on the phone or sifting through piles of paperwork, businesses with 2 to 50 employees can shop for healthcare coverage online. 3 Simple Steps-United Healthcare Through the site’s self-service system, you as a business owner can easily evaluate various plans and quotes. Rather than merely looking at estimates, you’ll be able to see the actual prices you will be paying based on the information you enter. In turn, your employees will be able to choose from multiple healthcare options, and in some cases, from as many as 27 different plans.

Getting Started

When you first access the site, you will get an overview of what the entire process will be like. Then you will enter your ZIP code, as well as the number of employees you will be covering, including yourself. Zip Code-United Healthcare Your next step is selecting the options you want to provide for your employees. You can determine the coverage you want to offer based upon a variety of factors, including cost. Once you select your plans, your employees will be able to choose which ones are best for them.

This flexibility is extremely helpful since some employees will need to cover spouses and dependents, while others will not. The setup also provides for people who have health issues that are more demanding than those of their coworkers.

Preview Your Actual Expenses

One of the most helpful features of United Healthcare’s new site is that you can calculate your actual costs before purchasing or even signing up for an account. When you begin evaluating your choices, you’ll input your employee information, either manually or by importing it from another application, such as Excel, QuickBooks, or Xero.

At this point in the process, you can create an account if you wish or wait to do so until later. Add Employees-United Healthcare Once you’ve entered your employee data, you can then view your cost per employee. That will help you determine the amount you want to budget for each one. You can set the amount you wish to pay for each employee as a fixed dollar amount or as a percentage of the total cost. Do note that this option depends on the state in which your business resides. Set Your Budget-United Healthcare United Healthcare enables you to view a couple different breakdowns of your expenses. You’ll be able to see the total fixed amount you will be spending on health insurance each month. You’ll also be able to see the total range your employees will be spending, depending on the plans they choose.

On the other hand,  you can also see what you’ll be paying per person, in addition to what each individual will pay based upon his or her plan choice. Employee Costs Breakdown-United Healthcare And if you realize you need to make adjustments to any of your information, you have the ability to go back and do so until you come up with the budget and plans that work best for your situation. You will need to create an account at this point if you have not done so yet, after which you will be able to view a diagram that lays out all of the details of your package. Then all you need to do is fill in the necessary information to check out and pay.

Assistance and More Customization

If you need assistance at any point, there are links throughout the shopping process to help you. There is also a “Contact Coverage Advisor” button at the top right corner of the webpage. Once you have completed your purchase, your employees will be able to easily choose health plans tailored to their needs.

They will also have access to videos and how-tos that will make the shopping process simpler for them. What’s more, in December United will roll out a feature that will make the system even more customized.

With this addition, when employees log in to evaluate their healthcare options, they will answer questions about their lifestyles and personas. Their answers to those questions will help them to select coverage best suited to their unique situations.

Where Can You Take Advantage of the New Site?

Select a State-United Healthcare United Healthcare’s new site is currently available in the following 15 states:

  • Arkansas
  • California
  • Florida
  • Illinois
  • Indiana
  • Kentucky
  • Maryland
  • Michigan
  • North Carolina
  • Ohio
  • Pennsylvania
  • Tennessee
  • Virginia
  • West Virginia
  • Wisconsin

The company plans to increase the site’s availability throughout the country in 2017.

Self-Service at Its Finest

Everyone is busy and, truth be told, most people are not overly excited about shopping for health insurance. For this reason, it’s highly beneficial to have a resource that provides an excellent user experience and makes shopping for insurance as simple and convenient as possible.

With this in mind, check out Enter to Win $50 Amazon Gift Card: United Healthcare Is the Easy Choice for Small Businesses #ad